(Q36446871)

14 August 2017

1 reference

title

A public health approach to pharmacogenomics and gene-based diagnostic tests (English)

1 reference

14 August 2017

0 references

1 reference

2

Muin J Khoury

1 reference

14 August 2017

Robert L Davis

1

1 reference

14 August 2017

language of work or name

1 reference

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

331-337

1 reference

A vision for the future of genomics research

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Integrating pharmacogenetics into society: in search of a model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Pharmacogenetics and drug development: the path to safer and more effective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Controlling spending for prescription drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Evidence-based coverage policy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Shattuck Lecture--Hidden barriers to improvement in the quality of care

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Defining the balance of risk and benefit in the era of genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Better information for better health care: the Evidence-based Practice Center program and the Agency for Healthcare Research and Quality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

What kind of evidence is it that Evidence-Based Medicine advocates want health care providers and consumers to pay attention to?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Prevention and primary care research for children. The need for evidence to precede "evidence-based".

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Drug metabolism and variability among patients in drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Challenges in using nonrandomized studies in systematic reviews of treatment interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

A network of investigator networks in human genome epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Genomic epidemiology of complex disease: the need for an electronic evidence-based approach to research synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Trials: the next 50 years. Large scale randomised evidence of moderate benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

NIH Director Elias A. Zerhouni, MD, reflects on agency's challenges, priorities. Interview by Catherine D. DeAngelis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

The U.S. pediatric cancer clinical trials programmes: international implications and the way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Priorities and standards in pharmacogenetic research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Group Health Cooperative of Puget Sound

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

The case for a global human genome epidemiology initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Improvements in medicare coverage of new technology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

Ensuring the appropriate use of genetic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.3.331

21 January 2018

Identifiers

DOI

10.2217/14622416.7.3.331

1 reference

14 August 2017

1 reference